Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab have?
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab has 92 citations in the OpenAlex counts ScholarIQ stores.
When was Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab published?
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab has 2018 year in the ScholarIQ index.
What is the open-access status of Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab?
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab has closed oa status in the ScholarIQ index.
What is the DOI of Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab?
The DOI for Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab is on the source record.
What is the PMID of Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab?
The PMID for Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab is on the source record.
What is the OpenAlex record for Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab?
The OpenAlex for Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab is on the source record.